• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.间变性甲状腺癌中癌症干细胞标志物及上皮-间质转化相关因子的表达
Int J Clin Exp Pathol. 2015 Jan 1;8(1):560-8. eCollection 2015.
2
Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.间变性甲状腺癌中与干性表型相关的上皮-间质转化的免疫组织化学检测
Int J Clin Exp Pathol. 2010 Oct 1;3(8):755-62.
3
Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.乳头状和间变性甲状腺癌中改变的生物标志物表达谱:突尼斯患者的贡献
Bull Cancer. 2017 May;104(5):433-441. doi: 10.1016/j.bulcan.2016.12.001. Epub 2017 Feb 6.
4
Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.与甲状腺乳头状癌相比,间变性甲状腺癌中癌干细胞标志物的表达更为频繁,并且与不良临床结局相关。
J Clin Pathol. 2014 Feb;67(2):125-33. doi: 10.1136/jclinpath-2013-201711. Epub 2013 Aug 28.
5
The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma.Notch1信号通路在间变性甲状腺癌中的作用
Cancer Res Treat. 2017 Apr;49(2):509-517. doi: 10.4143/crt.2016.214. Epub 2016 Sep 1.
6
The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.上皮间质转化标志物在甲状腺癌进展中的作用。
Endocr Pathol. 2013 Dec;24(4):206-12. doi: 10.1007/s12022-013-9272-9.
7
Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.间变性甲状腺癌的罕见表现:BRAF 突变分析的作用。
J Korean Med Sci. 2017 Oct;32(10):1721-1726. doi: 10.3346/jkms.2017.32.10.1721.
8
Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.间变性甲状腺癌中的癌干细胞样细胞行为:一个具有挑战性的难题。
Life Sci. 2016 Feb 1;146:34-9. doi: 10.1016/j.lfs.2015.12.057. Epub 2016 Jan 7.
9
Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells.HNHA 和仑伐替尼通过抑制癌症干细胞 EMT 介导的耐药性发挥抗癌作用。
Neoplasia. 2018 Feb;20(2):197-206. doi: 10.1016/j.neo.2017.12.003. Epub 2018 Jan 12.
10
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer.甲基乙二醛在间变性甲状腺癌中充当肿瘤促进因子。
Cells. 2019 Jun 6;8(6):547. doi: 10.3390/cells8060547.

引用本文的文献

1
Acute chromatin decompaction stiffens the nucleus as revealed by nanopillar-induced nuclear deformation in cells.纳米柱诱导细胞中的核变形揭示,急性染色质解压缩会使细胞核变硬。
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2416659122. doi: 10.1073/pnas.2416659122. Epub 2025 May 9.
2
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics.间变性甲状腺癌球体作为临床前模型用于测试治疗方法。
J Exp Clin Cancer Res. 2024 Mar 19;43(1):85. doi: 10.1186/s13046-024-03009-8.
3
Harnessing cancer stem cell-derived exosomes to improve cancer therapy.利用癌症干细胞衍生的外泌体来改善癌症治疗。
J Exp Clin Cancer Res. 2023 May 23;42(1):131. doi: 10.1186/s13046-023-02717-x.
4
Development of Novel Murine BRAF-Driven Papillary Thyroid Cancer Cell Lines for Modeling of Disease Progression and Preclinical Evaluation of Therapeutics.开发用于疾病进展建模和治疗药物临床前评估的新型小鼠BRAF驱动的甲状腺乳头状癌细胞系。
Cancers (Basel). 2023 Jan 31;15(3):879. doi: 10.3390/cancers15030879.
5
OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer.OVOL2 通过抑制 RHO GTPase 信号通路来抑制间变性甲状腺癌的有丝分裂和侵袭能力。
J Exp Clin Cancer Res. 2022 Mar 25;41(1):108. doi: 10.1186/s13046-022-02316-2.
6
Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers.我们能否预测分化型甲状腺癌的行为?遗传和分子标志物的作用。
Medicina (Kaunas). 2021 Oct 19;57(10):1131. doi: 10.3390/medicina57101131.
7
Osteoclasts in Tumor Biology: Metastasis and Epithelial-Mesenchymal-Myeloid Transition.肿瘤生物学中的破骨细胞:转移和上皮-间充质-髓样转化。
Pathol Oncol Res. 2021 Apr 30;27:609472. doi: 10.3389/pore.2021.609472. eCollection 2021.
8
LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels.LINC01816 通过海绵吸附 miR-34c-5p 并调节 CRABP2 表达水平促进甲状腺癌细胞的迁移、侵袭和上皮间质转化。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8032. Epub 2021 Mar 31.
9
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.甲状腺癌:表型特征、潜在生物学及对靶向治疗的潜在相关性。
Int J Mol Sci. 2021 Feb 16;22(4):1950. doi: 10.3390/ijms22041950.
10
Knockdown of Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375.通过靶向miR-375抑制甲状腺乳头状癌细胞的侵袭和转移。 (注:原文“Knockdown of ”后面缺少具体内容,这里只能根据大致意思翻译,补充完整可能是“某种基因或蛋白的敲低”之类的表述)
Cancer Manag Res. 2020 Sep 22;12:8757-8771. doi: 10.2147/CMAR.S243767. eCollection 2020.

本文引用的文献

1
New therapeutic options for advanced forms of thyroid cancer.晚期甲状腺癌的新治疗选择。
Expert Opin Emerg Drugs. 2014 Jun;19(2):225-41. doi: 10.1517/14728214.2014.894017. Epub 2014 Mar 3.
2
The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.上皮间质转化标志物在甲状腺癌进展中的作用。
Endocr Pathol. 2013 Dec;24(4):206-12. doi: 10.1007/s12022-013-9272-9.
3
Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers.甲状腺癌干细胞与甲状腺癌中的上皮-间充质转化。
Hum Pathol. 2013 Sep;44(9):1707-13. doi: 10.1016/j.humpath.2013.01.009. Epub 2013 Mar 22.
4
Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.甲状腺癌中上皮-间充质转化调节因子 SNAI2 和 TWIST1 的表达。
Mod Pathol. 2013 Jan;26(1):54-61. doi: 10.1038/modpathol.2012.137. Epub 2012 Aug 17.
5
Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.二甲双胍抑制甲状腺癌细胞生长,抑制衍生的肿瘤干细胞自我更新,并增强化疗药物的作用。
J Clin Endocrinol Metab. 2012 Apr;97(4):E510-20. doi: 10.1210/jc.2011-1754. Epub 2012 Jan 25.
6
BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.BRAF、p53 和 SOX2 在间变性甲状腺癌中的表达:多步骤致癌的证据。
Pathology. 2011 Aug;43(5):447-52. doi: 10.1097/PAT.0b013e3283486178.
7
Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?癌症干细胞和上皮-间充质转化(EMT)表型细胞:它们是表亲还是双胞胎?
Cancers (Basel). 2011 Feb 21;3(1):716-29. doi: 10.3390/cancers30100716.
8
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.TWIST1 在决定间变性甲状腺癌表型方面起着多效作用。
J Clin Endocrinol Metab. 2011 May;96(5):E772-81. doi: 10.1210/jc.2010-1182. Epub 2011 Mar 9.
9
Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.BRAF 诱导的甲状腺癌的进展与上皮-间充质转化有关,需要同时激活 MAP 激酶和 TGFβ 信号通路。
Oncogene. 2011 Jul 14;30(28):3153-62. doi: 10.1038/onc.2011.44. Epub 2011 Mar 7.
10
Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma.间变性甲状腺癌中与干性表型相关的上皮-间质转化的免疫组织化学检测
Int J Clin Exp Pathol. 2010 Oct 1;3(8):755-62.

间变性甲状腺癌中癌症干细胞标志物及上皮-间质转化相关因子的表达

Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.

作者信息

Jung Chang Won, Han Kang Hee, Seol Hyesil, Park Sunhoo, Koh Jae Soo, Lee Seung-Sook, Kim Min Joo, Choi Ik Joon, Myung Jae Kyung

机构信息

Department of Pathology, Korea Cancer Center Hospital Seoul, Korea.

Department of Pathology, Korea Cancer Center Hospital Seoul, Korea ; Laboratory of Radiation Pathology, Korea Cancer Center Hospital Seoul, Korea.

出版信息

Int J Clin Exp Pathol. 2015 Jan 1;8(1):560-8. eCollection 2015.

PMID:25755746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4348894/
Abstract

BACKGROUND

Anaplastic thyroid carcinoma (ATC) is an undifferentiated tumor of the thyroid that has poor prognosis owing to its aggressive behavior and resistance to current treatments. We hypothesized that the stem cell properties induced by the epithelial-mesenchymal transition (EMT) was one of reasons for the dismal outcome of ATC.

MATERIALS AND METHODS

Paraffin blocks and slides of 17 ATC cases were retrieved. We also collected 60 cases of papillary thyroid carcinoma (PTC) for comparison. We used immunohistochemistry to examine the expression of multiple markers of cancer stem cells and EMT-activating transcriptional factors.

RESULTS

Majority of ATC cases showed loss of epithelial (E)-cadherin expression (15/17); however, all PTC cases (60/60) retained E-cadherin expression. EMT-activating transcription factors, such as snail and slug, were more frequently expressed in ATC than PTC cases (35.3% versus 6.7%, 76.5% versus 5%, respectively). Cancer stem cell markers such as CD133 and nestin were more highly expressed in ATC than PTC (52.9% versus 5%, 52.9% versus 0%, respectively).

CONCLUSION

We found that the expression of EMT-related factors and stem cell markers was higher in ATC than PTC. We therefore conclude that stemness induced by EMT plays an important role in the pathogenesis of ATC.

摘要

背景

间变性甲状腺癌(ATC)是一种甲状腺未分化肿瘤,因其侵袭性生物学行为和对现有治疗的抵抗性而预后较差。我们推测,上皮-间质转化(EMT)诱导的干细胞特性是ATC预后不良的原因之一。

材料与方法

收集17例ATC病例的石蜡块和切片。我们还收集了60例甲状腺乳头状癌(PTC)病例用于比较。我们采用免疫组织化学法检测癌干细胞和EMT激活转录因子多种标志物的表达。

结果

大多数ATC病例显示上皮型(E)-钙黏蛋白表达缺失(15/17);然而,所有PTC病例(60/60)均保留E-钙黏蛋白表达。EMT激活转录因子,如蜗牛蛋白和蛞蝓蛋白,在ATC病例中的表达频率高于PTC病例(分别为35.3%对6.7%,76.5%对5%)。癌干细胞标志物如CD133和巢蛋白在ATC中的表达高于PTC(分别为52.9%对5%,52.9%对0%)。

结论

我们发现EMT相关因子和干细胞标志物在ATC中的表达高于PTC。因此,我们得出结论,EMT诱导的干性在ATC发病机制中起重要作用。